Adnan Kastrati
The ISAR group of trials and numerous scientific publications have addressed the most clinically relevant questions at the time. As a result, trial outcomes have been directly relevant to clinical practice and immediately useful in addressing unmet medical needs.
Latest contributions
Remaining challenges and role of innovative DES technology in complex PCI
20 May 2026 – From EuroPCR 2026
What still limits optimal outcomes in complex PCI, and how can current tools help overcome these barriers? Through three detailed case-based discussions, this EuroPCR 2026 session explores challenging clinical scenarios, including CTO, left main bifurcation, and complex PCI in a diabetic patient.
Each case highlights how advanced...
Which device for which patient: DES, BRS or DCB?
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.
Andreas Grüntzig Ethica Awardees
19 Jul 2017
Discover the list of all the Andreas Grüntzig Ethica Awardees.
